[go: up one dir, main page]

AR013509A1 - Formulaciones parasiticidas - Google Patents

Formulaciones parasiticidas

Info

Publication number
AR013509A1
AR013509A1 ARP980104712A ARP980104712A AR013509A1 AR 013509 A1 AR013509 A1 AR 013509A1 AR P980104712 A ARP980104712 A AR P980104712A AR P980104712 A ARP980104712 A AR P980104712A AR 013509 A1 AR013509 A1 AR 013509A1
Authority
AR
Argentina
Prior art keywords
parasiticide formulations
parasiticide
formulations
omilbemycin
avermectin
Prior art date
Application number
ARP980104712A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of AR013509A1 publication Critical patent/AR013509A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La invencion aporta un implante solido que comprende al menos un compuesto parasiticida que tiene una baja solubilidad acuosa como avermectina omilbemicina y excipientes de compresion entre los que se incluye un agente de relleno. Los implantes deacuerdo con la invencion son comodos de administrary proporcionan una proteccion prolongada frente a parásitos.
ARP980104712A 1997-09-23 1998-09-21 Formulaciones parasiticidas AR013509A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
AR013509A1 true AR013509A1 (es) 2000-12-27

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104712A AR013509A1 (es) 1997-09-23 1998-09-21 Formulaciones parasiticidas

Country Status (13)

Country Link
EP (1) EP1014970A1 (es)
JP (1) JP2001517622A (es)
AP (1) AP9801350A0 (es)
AR (1) AR013509A1 (es)
AU (1) AU9742298A (es)
BR (1) BR9812385A (es)
CA (1) CA2304283A1 (es)
GT (1) GT199800149A (es)
MA (1) MA24655A1 (es)
PA (1) PA8459501A1 (es)
PE (1) PE117199A1 (es)
TN (1) TNSN98175A1 (es)
WO (1) WO1999015166A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
US20200179273A1 (en) * 2017-06-06 2020-06-11 Merck Sharp & DohmeCorp Long-action implant for treatment of infectious diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
CA2304283A1 (en) 1999-04-01
PE117199A1 (es) 1999-11-20
GT199800149A (es) 2000-03-15
BR9812385A (pt) 2000-09-12
WO1999015166A1 (en) 1999-04-01
TNSN98175A1 (fr) 2005-03-15
MA24655A1 (fr) 1999-04-01
JP2001517622A (ja) 2001-10-09
PA8459501A1 (es) 2000-05-24
EP1014970A1 (en) 2000-07-05
AP9801350A0 (en) 2000-03-17
AU9742298A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
PA8554501A1 (es) Composicion fungicida basada en derivados de arilamidina y compuestos fungicos conocidos
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
HN1999000066A (es) Formulaciones farmaceuticas
NO20040917L (no) Oftamologiske depotpreparater for periokular eller subkonjunktival administrering.
ES2161210T3 (es) Composiciones anti-patogenamente eficaces que comprenden peptidos liticos y enzimas hidroliticas.
GT199800037A (es) Combinaciones para diabetes de sulfonilurea - glitazona.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
AR013509A1 (es) Formulaciones parasiticidas
UY28038A1 (es) Nuevas formulaciones de liberación propongada inyectables
ES2195189T3 (es) Benzonaftiridinas como agentes terapeuticos bronquiales.
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
ES2174199T3 (es) Utilizacion de un poliholosido para estimular las defensas inmunitarias.
CU23113A3 (es) Represion de artropodos en animales
CO4410176A1 (es) Formulaciones farmaceuticas de cefaclor
TR199901209T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
CO4750591A1 (es) Procedimiento de lucha contra los insectos
BR0311479A (pt) Derivados de tiofeno antelmìnticos e inseticidas
MY128682A (en) Synergistic insecticidal compositions
MX9100441A (es) Procedimiento para fabricar preparados solidos orales,que contienen ifosfamida como agente activo
GT200100218A (es) Compuesto agroquimico.
ES2191426T3 (es) Composiciones estables que comprenden levosimendano y acido alginico.
ES2185310T3 (es) Agente antivirico herbario.
ES2161913T3 (es) Complejos cationicos trinucleares de platino que tienen una actividad antitumoral y composiciones farmaceuticas que los contienen.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.

Legal Events

Date Code Title Description
FB Suspension of granting procedure